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Nutrigenomic research may uncover the keys to utilizing genetic
information to create food products that improve public health 
through mitigation of chronic diseases.
Nutrigenomics 
and Public Health
Nutrigenomics is a relatively new and very fast-moving field of research which combines 
molecular biology, genetics, and 
nutrition. It focuses on the role of 
nutritional status or specific nutri-
ents in the regulation of gene 
expression (Afman and Muller, 
2006; Komduur et al., 2009; Mead, 
2007). While one of its effects may 
be the development of personal diets 
based on an individual’s genetic code 
and focused on optimizing the 
expression of certain genes therein, 
other health-related outcomes show 
more promise at this juncture and 
have greater implications for public 
health promotion (Ordovas and 
Corella, 2004; Muller and Kersten, 
2003). Of significant interest is the 
potential for greater knowledge of 
how diet may influence disease state 
at the gene or molecular levels. 
Many threats to public health, 
including cancer, diabetes, obesity 
and other chronic diseases, are influ-
enced to a certain extent by genetic 
factors. The prevalence of cardiovas-
cular disease, diabetes, and other 
related conditions in the United 
States is shown in Figure 1.
Traditionally, many recom-
mendations for diet intake have 
been population based due to find-
ings from epidemiology studies. 
For instance, recommendations 
to lower fat intake for a popula-
tion are due to a link between fat 
intake and heart disease. However, 
not all individuals who consume 
a high-fat diet will develop heart 
disease. If we know who has a 
genetic susceptibility to a type 
of heart disease associated with 
elevated blood cholesterol, then 
perhaps diets can be tailored to 
those individuals. With the comple-
tion of the human genome project 
and continuous identification of 
the role of human genes, more 
information on who may be more 
likely to develop certain diseases 
and whether diet can prevent the 
expression of these diseases is an 
area of fundamental research.
The impact of nutrigenomics 
is not limited to public health. The 
food science and culinary industries 
may benefit from the information 
revealed by nutrigenomic research, 
and may also take advantage of 
opportunities to promote pub-
lic health in a more active way. 
Understanding the impact of pro-
cessing on food composition, added 
to new information regarding 
nutrients’ effects on genetics and 
disease processes, will afford new 
chances to improve public health 
through everyday manufacturing 
and food-processing practices. One 
such opportunity is the further 
development of functional foods 
with higher nutritional and sen-
sory quality (Ferguson, 2009).   
This article will focus on the 
potential public health impact of 
information gleaned from nutrig-
enomic research. We will explore 
how genes affect disease, and the ways 
in which nutrients affect genes. We 
will then discuss the potential impact 
of nutrient intake on disease state in 
light of current food consumption 
trends. Finally, we will outline how 
the food and culinary industries may 
take advantage of this information, 
and opportunities for exerting a 
positive influence on public health. 
Genetic Regulation  
of Disease State
It has long been recognized that a 
family history of various chronic dis-
eases increases an individual’s risk for 
developing such diseases. In general, 
the closer the genetic relationship 
between a patient and an affected 
family member, the greater the 
risk that the patient might develop 
the disease in question. The best 
explanation for this phenomenon 
is that many chronic diseases are 
regulated not only by lifestyle factors 
and environmental influences, but 
also by some genetic component. 
Since the advent of sensitive 
molecular biology procedures, 
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many genes partially responsible 
for the development of chronic 
disease have been suggested, and 
some have been confirmed.  Among 
these, perhaps the most well known 
are the oncogenes. Oncogenes are 
genes which code for proteins that 
control cell death, or apoptosis; or 
which control cell division and pro-
liferation (Croce, 2008). Rapid cell 
proliferation or inhibition of apop-
tosis may cause a cell to become 
cancerous, and begin the growth of 
lesions which may, in turn, become 
tumors. Which mechanism causes 
the onset of cancer is dependent 
on the specific oncogene and tissue 
type involved (Land et al., 1983).   
Another chronic disease with 
vast implications for public health 
is cardiovascular disease. Common 
biochemical markers for elevated 
cardiovascular risk include nonspecific 
indices of systemic inflammation, and 
their elevation is associated with car-
diovascular risk, although they may be 
elevated due to more acute conditions 
such as infection. It has been dem-
onstrated that the circulating levels 
of these markers may be influenced, 
at least in part, by various genetic 
factors (Pankow et al., 2001). Other 
genetic factors have also shown an 
effect in regulating the overall energy 
balance of an individual, contribut-
ing to the degree of one’s obesity or 
leanness (Barsh et al., 2000). These 
findings may influence how cardio-
vascular disease risk is diagnosed.
Hyperinsulinemia and diabetes 
are examples of chronic conditions 
plaguing the general public which 
have their origins, or partial ori-
gins, in genetics. Defective genetic 
regulation of several proteins which 
respond to the presence of insulin 
may be implicated in the etiology 
of type 2 diabetes. Ducluzeau et al. 
(2001) found decreased expression 
of key proteins and their mRNA 
in type 2 diabetic patients, and 
observed a lack of response to the 
presence of insulin by up-regulation 
of key response proteins. This lack of 
response is linked to defective expres-
sion of the genes for these proteins in 
response to insulin. Type 1 diabetes 
is reliant on genetic components to 
a greater degree than type 2 diabe-
tes because the genetic regulation 
of type 1 diabetes is polygenic, or 
accomplished by several genes.    
Nutrient Regulation of Gene Expression
In some cases, intake or levels of 
specific nutrients have been shown 
to directly impact gene expres-
sion. Often, this occurs by means 
of transcription factors. Tran-
scription factors are biochemical 
entities which bind to the DNA 
and either promote or inhibit 
transcription of genes. Several 
nutrients are known to bind to 
transcription factors and regulate 
gene expression in this manner 
(Muller and Kersten, 2003).
The regulation of gene tran-
scription by fatty acids is perhaps 
the best understood of the nutri-
ent gene-regulation pathways. A 
major pathway by which fatty acids 
modulate gene expression is the 
peroxisome proliferator-activated 
receptors (PPARs), which activate 
gene transcription when fatty acids 
bind to them (Bouwens et al., 
2007). One such receptor has been 
shown to activate genes respon-
sible for utilization of fatty acids 
for energy (Kresten et al., 1999). 
Circulating fatty acid concentrations 
are increased during fasting. These 
fasting-induced amplified fatty acid 
concentrations increase the expres-
sion of several genes involved in 
β-oxidation of fatty acids (Bouwens 
et al., 2007). One of the isoforms 
of PPAR is PPARα, which is a 
nuclear receptor that binds to the 
promoters of genes whose prod-
ucts favor fatty acid breakdown 
(Madrazo and Kelly, 2008). How-
ever, these receptors need activators 
to realize their full potential. Fatty 
acids can act as ligands to PPARα, 
such as oleic acid, to enhance activ-
ity (Michaud and Renier, 2009). 
Furthermore, the PPARs do not act 
by themselves but require another 
partner, the retinoic acid receptors 
with cis-retinoic acid as a ligand. 
Thus, fatty acid catabolism is some-
what dependent upon cis-retinoic 
acid or any other nutrient or drug 
that enhances the activity of  
the nuclear receptors (Figure 2). 
Also, PPAR activity activation 
may lead to weight loss (Verreth 
et al., 2004). However, much has 
been done in developing drugs to 
act as ligands to both PPARα and 
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Figure 1. Prevalence of chronic diseases and related states in the United States (2006).
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PPARγ; perhaps the same approach 
may be taken by the food industry 
(Robinson and Grieve, 2009).
Dietary carbohydrate intake has 
also been implicated in the regula-
tion of gene expression. Glucose 
consumption is a crucial determi-
nant of the rate of transcription 
in the liver of genes for several 
glycolytic enzymes and enzymes 
for fatty acid synthesis, as well as 
lipoproteins and insulin (Clarke 
and Abraham, 1992). However, 
this effect has also been observed 
in other tissues such as the pan-
creas (German et al., 1990).
Vitamins and minerals may 
also have transcriptional regula-
tion properties. Retinoic acid, 
a form of vitamin A, forms part 
of transcription factors which 
may bind to the promoter region 
of genes involved in embryonic 
development and cell differen-
tiation (DeLuca, 1991). Divalent 
minerals, such as iron, copper, 
and zinc, alter the transcription 
rates of genes for proteins such as 
metallothionein, a crucial trans-
port and storage protein for these 
minerals (Bremener and Beattie, 
1990). Probably the most notable 
nutrient gene interaction deals 
with vitamin D and the vitamin 
D nuclear receptor. Here, 1, 25 
dihydroxycholecalciferol binds 
with the nuclear receptor, and in 
the nucleus this complex binds to 
promoters of genes that encode 
for many proteins. In essence, 
the role of vitamin D appears to 
favor pathways involved with cell 
differentiation and inhibits path-
ways favoring cell proliferation. 
Hence, this may have an impact on 
cancer as cell proliferation versus 
differentiation must be kept in bal-
ance (Samuel and Sitrin, 2008).
Folate metabolism may have 
variations among populations. When 
there is a mutation in one nucleotide 
base pair that alters the function of 
the protein that occurs in more than 
1% of the population, this is termed 
a single nucleotide polymorphism 
or SNP. Folate synthesis in some 
populations may be limited due to 
SNP and thus more dietary folate 
may be required (Martínez de Villar-
real, 2001). A lack of folate during 
pregnancy can lead to spina bifida 
birth defects. A Mexican study sug-
gested an increased risk of colorectal 
cancer with a particular type of 
polymorphism (Gallegos-Arreola 
et al., 2009). Diets customized to 
provide extra folate to those with 
these SNP profile could be devel-
oped. Overall, food may impact the 
cell by direct interaction with DNA 
(genes), RNA, protein, or other 
metabolites. Knowing these roles 
of nutrients and how each of these 
cell components may cause diseases 
will allow food to be tailored to 
an individual’s genetic make-up.
Nutrigenomics and Food Processing
Having discussed the ability of 
various nutrients to impact gene 
expression and the ability of genes 
to influence disease progres-
sion, examination of the impacts 
of processing techniques on the 
nutrient content or quality of sev-
eral foods is appropriate. It may be 
that food processing or prepara-
tion practices can change levels of 
nutrients which will impact genes 
regulating disease processes. If 
this is the case, consideration of 
current industry practices may be 
in order. In general, most food 
preservation processes lead to 
diminished nutritional quality for 
food products, of course, the chal-
lenge being to balance food safety 
issues with nutritional aspects.
Traditional methods such as 
canning and freezing have been 
shown to have detrimental effects 
on nutritional quality of food 
products (Schroeder, 1971; Hale 
and Brown, 1983; Aubourg, 1997; 
Slavin et al., 2001). Minimal pro-
cessing techniques are becoming 
more popular, especially with 
traditional and healthy food like 
fruits and vegetables (Allende et 
al., 2006). Other non-conventional 
techniques such as osmotic dehy-
dration, membrane processing, 
ultra high hydrostatic pressure, and 
high voltage pulsed electric fields 
to name a few are being explored 
more and more for food process-
ing applications (Ortega-Rivas, 
2007) to better preserve the nutri-
tional quality of processed foods. 
Implications for the Food 
and Culinary Industries 
How can nutrigenomic-related 
research and findings be applied by 
the food and culinary industries to 
promote health? A consumer accep-
tance study about nutrigenomics by 
Ronteltap et al. (2009) showed that 
people are open to this concept, 
provided that there is more com-
munication between the experts 
Figure 2. Illustration of how nutrients may influence gene activation. In this example, the nuclear receptors—retinoic acid receptor (RXR) and 
peroxisome proliferator-activated receptors (PPARα)—bind to the promoter of a gene involved in the breakdown of fatty acids, medium chain 
acyl dehydrogenase. To function, these nuclear receptors need a ligand to activate them. In this case, cis-retionic acid (vitamin A) activates the 
RXR receptor, and the monounsaturated fatty acid, oleic acid, activates the PPARα receptor. When both of the nuclear receptors are activated, a 
series of biochemical events is triggered that allows the gene to be turned on to synthesize the messenger RNA for protein synthesis.
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and consumers, and also more 
information should be made avail-
able to them. Although genetically 
sensitive foods are different from 
genetically modified foods, con-
sumer skepticism cannot be ruled 
out if the information about nutrig-
enomics is not conveyed properly 
to consumers (Archibald, 2004). 
According to Archibald (2004), a 
genetic counselor or a physician 
could help an individual understand 
his/her genetic makeup, and then 
the nutritional professional could 
tailor diets accordingly (Figure 3).
Let us suppose for example that 
since oleic acid enhances PPARα 
activity and therefore fatty acid 
oxidation, should food and culinary 
entities choose food high in oleic 
acid (i.e., peanut or olive oils) in 
some of their meals or menus? Dys-
functional PPARα activity has been 
implicated in diabetes and thus it is 
not inconceivable that providing a 
diet to enhance PPARα activity may 
prove beneficial. Indeed, oleic acid 
and peanut oil high in oleic acid have 
been shown to reverse the inhibi-
tory effect upon insulin production 
and can have a beneficial effect in 
type 2 diabetes (Vassiliou et al., 
2009). Flavonoids have been shown 
to enhance PPARα expression and 
normalize blood triglycerides in 
high-fat-fed diabetic rats (Kaviarasan 
and Pugalendi, 2009). While trying 
to develop these targeted products, 
the developers (food and culinary 
industries) and the practitioners 
(mainly registered dietitians and 
nutritional professional) must con-
sider the regulatory and legal issues 
associated with nutrigenomics. Since 
nutrigenomics is a relatively new 
field, work should be undertaken 
to develop proper ethical and legal 
guidelines to protect consum-
ers (Reilly and DeBusk, 2008). 
Future Discoveries
Current global trends in food 
consumption may have an impact 
on disease progressions observed 
worldwide. This impact may occur 
by means of nutrient regulation 
of genes, or by other unclear 
mechanisms which are yet to be 
discovered. There may be oppor-
tunities for the food industry to 
improve public health through 
modification of processing and 
production methods, as well as 
to capitalize on promotion of 
more positive trends. Nutrig-
enomic research may uncover 
the keys to utilizing genetic 
information to maximize public 
health and generally benefit the 
food and culinary industries.
The key to synthesizing this 
broad spectrum of information 
into a coherent picture may be the 
emerging field of nutrigenomics. 
Through nutrigenomic research, 
new nutritional regulation of gene 
expression will hopefully come to 
light. If specific nutrient regulation 
of genes closely related to disease 
onset or progression is identified, 
new arenas for disease preven-
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tion and potential for treatment 
will come to the foreground of 
nutritional research and preven-
tive medicine. Treatment and 
prevention plans based on nutri-
ent consumption will necessarily 
rely heavily on the available food 
supply, which, in turn, relies upon 
the food and culinary industries.
Maximum utilization of the 
information brought forth by 
nutrigenomic research is cru-
cial if these industries hope to 
promote public health. FT
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